Nattokinase Supplementation and Hemostatic Factors

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02913170

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02913170
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02913170. Randomized; triple masking; primary purpose supportive care. Start 2015-05 (registry gives no type); primary completion 2016-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nattokinase Supplementation and Hemostatic Factors
Condition
Hypercholesterolemia
Intervention (Dietary supplement)
Nattokinase
Intervention (Dietary supplement)
Placebo
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct02913170
Content hash
4eaef5d6f94aaf0337456288d6bdcbe34cbb1e382467d79173a4874c9525e9ea